ANGEN ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. Stock
Anatolia Tanı ve Biyoteknoloji Ürünleri Araştırma Geliştirme Sanayi ve Ticaret A.Ş., biyoteknoloji alanında tanı ürünleri geliştiren bir şirkettir. Kimya ve petrokimya sektöründe faaliyet göstermektedir.
| Period | Revenue | EBITDA | Net Income |
|---|---|---|---|
| 2026 Q1 | 181.9M | -51.2M | -163.7M |
| 2025 Q4 | 230.6M | -31.5M | -25.1M |
| 2025 Q3 | 203.3M | 3.1M | -98.4M |
| 2025 Q2 | 167.6M | -981K | -75.9M |
| 2025 Q1 | 138.1M | 10.1M | -93.5M |
| 2024 Q4 | 150.1M | 18.9M | -42.6M |
| 2024 Q3 | 157.2M | 14.6M | -459K |
| 2024 Q2 | 128.1M | 10.2M | -76.3M |
| Period | P/E (TTM) | TTM Net Income | E/P Quarterly | E/P Annual (TTM) |
|---|---|---|---|---|
| 2026 Q1 | — | -363.0M TRY | -0.0727 | -0.1613 |
| 2025 Q4 | — | -292.8M TRY | -0.0105 | -0.1231 |
| 2025 Q3 | — | -310.3M TRY | -0.0367 | -0.1159 |
| 2025 Q2 | — | -212.4M TRY | -0.0343 | -0.0959 |
| 2025 Q1 | — | -212.8M TRY | -0.0378 | -0.0861 |
| 2024 Q4 | — | -200.3M TRY | -0.0156 | -0.0736 |
| 2024 Q3 | — | -395.0M TRY | -0.0002 | -0.1320 |
| 2024 Q2 | — | -379.3M TRY | -0.0296 | -0.1473 |
| Period | Net Margin | Gross Margin | ROE | ROA | Debt/Equity | Rev. Growth (YoY) |
|---|---|---|---|---|---|---|
| 2026 Q1 | -90% | 44.8% | — | -25.2% | — | +31.7% |
| 2025 Q4 | -10.9% | 58.6% | — | -4.2% | — | +53.7% |
| 2025 Q3 | -48.4% | 68.7% | -23.4% | -18.3% | 0.06 | +29.3% |
| 2025 Q2 | -45.3% | 62.2% | -18.5% | -15.3% | 0.05 | +30.8% |
| 2025 Q1 | -67.7% | 65.7% | -23.2% | -19.7% | 0.03 | +46.3% |
| 2024 Q4 | -28.4% | 56.8% | -11% | -9.5% | 0.00 | +30.3% |
| 2024 Q3 | -0.3% | 63.9% | -0.1% | -0.1% | 0.01 | +215.7% |
| 2024 Q2 | -59.5% | 55.7% | -22.5% | -19.3% | 0.01 | +177.9% |
| Period | P/B |
|---|---|
| 2026 Q1 | 1.29 |
| 2025 Q4 | 1.37 |
| 2025 Q3 | 1.60 |
| 2025 Q2 | 1.35 |
| 2025 Q1 | 1.53 |
| 2024 Q4 | 1.75 |
| 2024 Q3 | 2.01 |
| 2024 Q2 | 1.90 |
What is the ANGEN stock price?
The current price of ANGEN is 10.24 TRY. (2026-07-17)
What is the ANGEN E/P ratio?
The annual (TTM) E/P ratio of ANGEN is -0.1613. Market cap: 2.3B TRY.
What sector is ANGEN in?
ANGEN (ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.) operates in the Kimya ve Petrokimya sector.
What is the ANGEN P/B ratio?
The P/B (Price-to-Book) ratio of ANGEN is 1.29.
ANGEN Stock Analysis — Borsa Istanbul
This page provides a comprehensive analysis of ANGEN (ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.), a company listed on Borsa Istanbul in the Kimya ve Petrokimya sector. The current share price, daily percentage change, and trading volume are updated at the end of each trading session using official BIST data.
Momentum and Technical Indicators
Short-term and medium-term momentum indicators for ANGEN are calculated using 21-day and 63-day return windows. The 21-day Sortino ratio measures risk-adjusted performance by penalizing only downside volatility, providing a cleaner signal than standard deviation-based metrics. Annualized volatility and 252-day (one-year) momentum are also displayed to help investors assess both trend strength and risk characteristics of ANGEN relative to its sector peers.
Fundamental Metrics
Key valuation ratios include the Earnings-to-Price (E/P) ratio calculated on both quarterly and trailing twelve-month (TTM) bases, the Price-to-Book (P/B) ratio derived from the most recent balance sheet equity, and market capitalization. Financial health indicators such as ROE (Return on Equity), ROA (Return on Assets), net profit margin, gross margin, and debt-to-equity ratio are sourced from the latest disclosed quarterly financial statements filed with KAP (Public Disclosure Platform).
Sector Comparison
ANGEN is compared against other stocks in the Kimya ve Petrokimya sector across momentum, valuation, and profitability dimensions. The sector comparison table ranks ANGEN against its peers using percentile scores, making it easy to identify whether the stock is relatively cheap (high E/P), growing faster (high momentum), or more profitable (high ROE) compared to the sector median. All data is refreshed daily and financial ratios are updated each quarter after earnings disclosures.